Healthcare Marketplace, week(1-5) All Quiz Answers with Assignments.

Share:
Healthcare Marketplace




week 1 Assignment :

PROMPT

Submit your answer to the assignment here.

1. Name three issues why Fortune 100 firm executives(i.e., big Business from the Marketplace Landscape map)care about the medical industry.

1) Monopolies allowed in the healthcare industrythrough patents
2) Payment for reimbursement through differentproviders or insurer
3) The potential market that could be differentcountries

2. What are two market conditions or regulations thatcould affect the issues? Describe and explain.
1) The duration of the patents
2) Reimbursement rate that insurers impose
3) In what way might the three issues (that youidentify in #1) diminish or not in the next five years? Whyand how? To what extent? In what way? etc. Describeand explain for each.

3.In the next 5 years I think the issues I identified inquestion number 1 will remain almost as they are today,but with more pressure for change:

1) Patents will continue but, perhaps, some actorsrequest a shorter duration, which allows faster access tocompetitors, such as generic or biosimilar products,which reduce cost and may increase access
.2) Innovation gives us new treatments that give usa longer life expectancy and with it the demand formedical care increases every year. Insurance tries toavoid high-cost treatments and increase the rigor ofpayments, as more and more people request healthcare services, and many of them are high-cost.
3) I think the potential market will increase in 5years, because more people will want to have access tonew technologies and treatments, so they could putpressure on governments or insurance to have them.

PROMPT

Submit your answers to all the assignment questions here. Approximately 2 pages in length.

The use of 3D printing is a new innovative approach inthe medical industry that is fast gaining so muchrelevance in the developed world today, 3D bio-printingis the use of additive manufacturing processes todeposit materials known as bioinks to create tissue-likestructures that can be used in the medical fields.Additive manufacturing as it is otherwise called wasdeveloped in the 1980s, having core uses that areassociated with recent innovations: creating tissues andorganoid, surgical tools, patient-specific surgical modelsand custom-made prosthetic.Patients that have lost a part of their body or an organwhich may have been malfunctioning or deaden orinfected with any irredeemable disease such as canceror gangrene will ultimately benefit from the 3D bioprinting technology. The level of its acceptance is gainingmileage recently in the developed world as it is a globallyidentified means of giving hope to patients who have orare almost giving up because of the loss of a vital bodypart or internal organ.Various sub-sectors that is involved in the use of 3Dprinting are the Physicians, Pharmaceuticalmanufacturers, tissue engineers, technologists,computer scientists, artificial intelligence etc. As thetechnology continues to evolve and grow in the medicalindustries, it will keep attracting new disciplines whomight soon identify their place in the proper andefficient running of this technology in the medical field.The geographic scale of the use of 3D is global, althoughthe developed nations are currently in use of thetechnology such as USA, China, India etc but soon thedeveloping countries will soon start to adopt the use ofthis fantastic means of treatment and rehabilitation topatients. The possibility of the use of the technology canreach the underdeveloped countries through thephilanthropic outreaches of the foremost countries inthe world.Partnering agents such as engineering associations,tissue engineers, FDA, NIH, VA along with physiciansfrom various specialties are needed to be involved in thesuccessful use, implementation and facilitation of theadoption of the new technology into the medical system.Return on investment on 3D printing is even possiblewithin a year as there are evidences already of return oninvestment in some french companies recently,calculating the ROI for a 3D machine or the 3D printingstarts from the calculation and determination of the costof a single printing, also worthy to note is that the moredifferent parts you print, the higher the return oninvestment, in order to maximize the investment on 3Dprinting there is need to really focus on the potential of3D, one of the benefits is the versatility with which youcan print a large number of different parts.Personally, If i have the means, i will bountifully invest inthis new medical technology as the opportunities of itssuccess abounds in the next couple of years, especiallyby 2022-2025.[198 Pages Report] The 3D printing medical devicesmarket is projected to grow from an estimated USD 0.84billion in 2017 to USD 1.88 billion by 2022, at a CAGR of17.5% during the forecast period. Market growth islargely driven by factors such as technologicaladvancements, increasing public-private funding for 3Dprinting activities, easy development of customizedmedical products, and growing applications in thehealthcare industry.

By component, the 3D printedequipment segment is expectedto grow at the highest rateduring the forecast period

On the basis of components, the 3D printing medicaldevices market is segmented into software & services,equipment (3D printers and 3D bioprinters), andmaterials (plastics, metal & metal alloys powder,bioprinting biomaterials, and others). In 2017, thesoftware & services segment accounted for the largestshare of the 3D printing medical devices market.Whereas, the 3D printing equipment segment is poisedto witness the highest growth rate during the forecastperiod.

By technology, thephotopolymerization segmentwas the largest contributor tothe 3D printing medical devicesmarket in 2017

Based on technology, the global 3D printing medicaldevices market is segmented into five broad categories,namely, electron beam melting, laser beam melting,photopolymerization, droplet deposition (DD) orextrusion-based technologies, and three-dimensionalprinting (3DP) or adhesion bonding or binder jetting. Thephotopolymerization technology segment commandedthe largest share of the global 3D printing medicaldevices market in 2017. This is attributed to thewidespread application of this technology across themedical industry, for manufacturing surgical guides(orthopedic, dental, and CMF guides), prosthetics andimplants, porous scaffolds, and dental restorations

The surgical guides segment wasthe largest contributor to the 3Dprintedprinted medical products marketin 2017

By type, the 3D-printed medical products market isfurther segmented into four major categories, namely,surgical guides, surgical instruments, prosthetics &implants, and tissue engineering products. The surgicalguides segment accounted for the largest share of the3D printing medical devices market in 2017. Theincreasing use of the digitally driven process foraccurate surgical planning is the key factor contributingto its market growth.

Asia Pacific is expected to growat the highest CAGR in the 3Dprinting medical devices marketduring the forecast period

Geographically, the 3D printing medical devices marketis segmented into four major regions, namely, NorthAmerica, Europe, the Asia Pacific, and the Rest of theWorld (RoW). The Asia Pacific is one of the major highgrowth revenue-generating regions in the 3D printingmedical devices market. The establishment of new 3Dprinting research, training, and education centers, andrising efforts by leading market players for expandingtheir distribution networks in emerging Asian countriesare factors propelling the growth of the 3D printingmedical devices market in Asia-Pacific.

Market Dynamics

The 3D printing medical devices market is primarilydriven by factors such as technological advancements,increasing public-private funding, easy development ofcustomized medical products, and growing applicationsin the healthcare industry. On the other hand, factorssuch as the stringent regulatory process and the dearthof trained professionals are expected to limit marketgrowth to a certain extent.However, direct digital manufacturing, thereconfiguration of supply chain models of medicaldevice manufacturers, the expiry of key patents in thecoming years, and the growing demand for organtransplant are expected to provide growth opportunitiesfor players in the market.

Driver:Technologicaladvancements in 3D printing

Various companies are increasingly focusing ondeveloping new 3D-printed products and technologiesto cater to the growing demand for 3D printing in thehealthcare industry. As traditional manufacturingprocesses are time-consuming and expensive, majorcompanies are engaged in the development of novelproducts and technologies, which are affordable andless time-consuming.
Restraint : Stringent regulatoryprocess for the approval of 3Dprintedmedical devices
Stringent regulatory guidelines (especially in the US) area major factor restraining the growth of the 3D printingmedical devices market. Simple 3D-printed devicesreceive FDA approval, but complex devices that need tocomply with a large number of FDA requirements are ahurdle for the availability of 3D-printed products on alarge scale. Moreover, state legal requirements andmanufacturing regulations become an obstacle fordispensing 3D-printed medicines

Key Market Players

Stratasys Ltd. (Israel and US), 3D SystemsCorporation (US), Materialise NV (Belgium), EnvisionTECGmbH (Germany), EOS GmbH Electro OpticalSystems (Germany), Renishaw plc (UK), Concept LaserGmbH (Germany), 3T RDP, Ltd. (UK), Prodways (France),Arcam AB (Sweden), Anatomics Pty Ltd (Australia),Biomedical Modeling Inc. (US), Carbon, Inc. (US), andSLM Solutions Group AG (Germany), Organovo Holdings,Inc. (US), among othersStratasys Ltd. (Israel & US) held the leading position inthe global 3D printing medical devices market in 2016.The company’s 3D printing product portfolio includes athe global 3D printing medical devices market in 2016.The company’s 3D printing product portfolio includes awide range of 3D printing systems and consumablesthrough which it caters to the demand of variousindustries, including automotive, consumer electronics,aerospace, dental, defense, education, commercialproducts, architecture, and medical. The company alsooffers services associated with its 3D printing products.The company primarily focuses on product innovationand new product launches as its key business strategy tosustain its leadership position in the global 3D printingmedical devices market.3D Systems Corporation (US) held the second position inthe 3D printing medical devices market in 2016. Thecompany incorporates a broad range of 3D printingsolutions in its product portfolio, comprising desktop 3Dprinters, print materials, cloud-sourced custom parts,and 3D digital design and fabrication solutions. Thecompany primarily focuses on expanding its 3D printingproduct portfolio in order to increase its share in theglobal 3D printing medical devices market.A concrete example:Let us continue with the calculation of the ROI:ROI = 100% * (Investment profit – Investment cost) /Investment costFor this example, let’s imagine we want to produce 400pieces.First of all, you need to calculate the return onFor this example, let’s imagine we want to produce 400pieces.First of all, you need to calculate the return oninvestment of a piece: CNC production cost – 3D printingcost is 169 € – 47 € = 122 €).As mentioned, the cost of CNC production would be 100€ (because we want to produce more than 100 pieces) –47 €= 53 €.Here you save 53 € per piece (the figure is different fromthe 122 € calculated above because the productionexceeds 100 pieces produced, the cost of processingthen goes from 169 to 100 € per piece).Then we went on to calculate the total investment gain:53 € * 400 pieces = 21,200 €.

ROI: return on investment

It is assumed that the investment cost is 13,499 €, whichis the price of the 3D printer in our case.Then, we proceed with the calculations to know the ROI:ROI = 100% * (Investment Gain – Investment Cost) /Investment CostSo:RE = 100% * (21 200 € – 13 499 €) / 13 499 €This gives us a total returnSo:RE = 100% * (21 200 € – 13 499 €) / 13 499 €This gives us a total return on investment: 7,701 € (21200 – 13 499). So:RE = 100%* 7 7 01 € / 13 499 €RE = 100%* 0.5704ROI = 57.04%.This number means that the 3D printer is alreadyprofitable (ROI is positive) but also that it has returned57.04% of its price to the company that purchased theprinter. In 400 pieces produced, the machine is alreadyrefunded and has already brought the money.Moreover, we have not taken into account the deliverytimes and costs in the calculation of the ROI, normallynecessary in the case of traditional production.In fact, the internalisation of the production processoffered by the acquisition of a 3D printer makes itpossible to produce everything directly and thuseliminate these additional costs.











No comments